Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects

Hypertension

Volumn 33, Issue 2, 1999, Pages 719-725

  Nazzaro, Pietro ^a   Manzari, Margherita ^b   Merlo, Massimo ^b   Triggiani, Rita ^b   Scarano, Annamaria ^b   Ciancio, Luigi ^b   Pirrelli, Anna ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NONE

Author keywords

Cardiovascular reactivity; Hypercholesterolemia; Hypertension; Plethysmography; Vascular damage

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; SYMPATHETIC TONE;

EID: 0033039589     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.2.719     Document Type: Article

References (48)

1. Julius S, Jamerson K, Mejia A, Krause L, Schork N, Kerin J. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA. 1990;264: 354-358.
2. Lemne C, Hamsten A, Karpe F, Nilsson-Hele P, deFaire U. Dyslipoproteinemic changes in borderline hypertension. Hypertension. 1994;24: 605-610.
3. Antony I, Nitenberg A. Coronary vascular reserve is similarly reduced in hypertensive patients without any other coronary risk factors and in normotensive smokers and hypercholesterolemic patients with angiographically normal coronary arteries. Am J Hypertens. 1997;10:181-188.
4. van Merode T, Hick P, Hoeks APG, Reneman RS. Serum HDL/total cholesterol ratio and blood pressure in asymptomatic atherosclerotic lesions of the cervical arteries in men. Stroke. 1985;16:34-38.
5. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, hypercholesterolemia, and hypertension. J Clin Invest. 1993;92:652-662.
6. Julius S, Mejia A, Jones K, Krause L, Shork N, van de Ven C, Johnson EH, Petrin J, Sekkarie A, Kjeldsen SE, Schmouder R, Gupta R, Ferraro J, Nazzaro P, Weissfeld J. 'White coat' versus 'sustained' borderline hypertension in Tecumseh, Michigan. Hypertension. 1990;16:617-623.
7. Muldoon MF, Herbert TB, Patterson SM, Kameneva M, Raible R, Manuck SB. Effects of acute psychological stress on serum lipids levels, hemoconcentration, and blood viscosity. Arch Intern Med. 1995;155: 615-620.
8. Jorgensen RS, Nash JK, Lasser NL, Hymanwitz N, Langer AW. Heart rate acceleration and its relationship to total serum cholesterol, triglycerides, and blood pressure reactivity in men with mild hypertension. Psychophysiology. 1988;25:39-44.
9. Weidner G, Sexton G, McLellarn R, Connor SL, Matarazzo JD. The role of type A behavior and hostility in an elevation of plasma lipids in adult women and men. Psychosom Med. 1987;49:136-145.
10. Johnson EH, Collier P, Nazzaro P, Gilbert DC. Psychological and physiological predictors of lipids in black males. J Behav Med. 1992;15: 285-298.
11. Julius S. The blood pressure seeking properties of the central nervous system. J Hypertens. 1988;6:177-185.
12. Santangelo KL, Falkner B, Kushner H. Forearm hemodynamics at rest and stress in borderline hypertensive adolescents. Am J Hypertens. 1989;2:52-56.
13. Barnett PA, Spence JD, Manuck SB, Jennings JR. Psychological stress and the progression of carotid artery disease. J Hypertens. 1997;15: 49-55.
14. Virdis A, Ghiadoni L, Lucanni A, Di Legge V, Taddei S, Salvetti A. Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term therapy. Am J Hypertens. 1996;9:361-369.
15. Novo S, Abrignani MG, Corda M, Strano A. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment. Eur Heart J. 1991;12(suppl G):47-53.
16. Eichstadt HW, Eskotter H, Hoffman I, Amthauer HW, Weidinger G. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. Am J Cardiol. 1995;76:122A-125A.
17. Spacil J, Ceska R, Subra J, Petrasek J. Decreasing common carotid artery intimal thickness during hypolipidemic therapy. Angiology. 1997;48: 761-767.
18. deLorgeril M, Salen P, Martin JL, Mamelle N, Monjaud I, Touboul P, Delaye J. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease: insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol. 1996;28:1103-1108.
19. Julius S. Changing role of the autonomic nervous system in human hypertension. J Hypertens. 1990;8(suppl 7):559-565.
20. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
21. Agabiti Rosei E, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, Bettoni G, Salvetti M, Muiesan P, Giulini SM. Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens. 1995;13:341-347.
22. Egan BM, Julius S. Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive. Clin Exper Hypertens. 1985;A7:242-255.
23. Chauhan A, Mullins PA, Taylor G, Petch MC, Schofield PM. Effect of hyperventilation and mental stress on coronary blood flow in syndrome X. Br Heart J. 1993;69:516-524.
24. Bravo EL. Metabolic factors and sympathetic nervous system. Am J Hypertens. 1989;2:339S-344S.
25. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension. 1995;25: 474-481.
26. Schmieder RE, Schobel HP. Is endothelial dysfunction reversible? Am J Cardiol 1995;76(suppl):117A-121A.
27. Libretti A, Catalano M. Lipid profile during antihypertensive treatment. The SLIP Study Group. Drugs. 1993;46(suppl 2):16-23.
28. Nazzaro P, Cicco G, Manzari M, Merlo M, Pirrelli A. Lipids and cardiovascular reactivity changes in hypertensive cigarette smokers: enalapril versus nifedipine treatment effects. Am J Med Sci. 1994;307(suppl 1):S150-S153.
29. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure. J Nucl Med. 1997;38:1085-1089.
30. Seidelin PH, Collier JG, Struthers AD, Webb DJ. Angiotensin II augments sympathetically mediated arteriolar constriction in man. Clin Sci. 1991;81:261-266.
31. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension. 1993;21:618-623.
32. Laine H, Knuuti MJ, Ruotsalainen U, Raitakari M, Iida H, Kapanen J, Kirvela O, Haaparanta M, Yki-Jarvinen H, Nuutila P. Insulin resistance in essential hypertension is characterized by impaired insulin stimulation of blood flow in skeletal muscle. J Hypertension. 1998;16:211-219.
33. Jiang J, Roman RJ. Lovastatin prevents development of hypertension in spontaneously hypertensive rats. Hypertension. 1997;30:968-974.
34. Hayoz D, Weber R, Rutschmann B, Darioli R, Burnier M, Waeber B, Brunner HR. Postischemic blood flow response in hypercholesterolemic patients. Hypertension. 1995;26:497-502.
35. Treasure CB, Klein JL, Weintraub WS, Talley DJ, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995;332:481-487.
36. Albaldaejo P, Bouaziz H, Duriez M, Gohlke P, Levy B, Safar M, Benetos A. Angiotensin-converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension. 1994;23:74-82.
37. Hall A. The cellular functions of small GTP-binding proteins. Science. 1990;249:635-654.
38. Soma MR, Donetti E, Parolinic C, Mazzini G, Ferrari C, Fumagalli R, Paoletti R. HMG-CoA reductase inhibitors: in vivo effects on carotid intimal thickening in nonnocholesterolemic rabbits. Arterioscler Thromb. 1993;13:571-578.
39. Gerin W, Pickering TG. Association between delayed recovery of blood pressure after acute mental stress and parental history of hypertension. J Hypertens. 1995;13:603-610.
40. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. 1990;300:230-235.
41. Linden W, Earle TL, Gerin W, Christenfeld N. Physiological stress reactivity and recovery: conceptual siblings separated at birth? J Psychosom Res. 1997;42:117-135.
42. Nazzaro P, Manzari M, Merlo M, Soleti F, Marella N, Pirrelli A. Anti-hypertensive treatment with verapamil and amlodipme: their effect on the functional autonomic and cardiovascular stress responses. Eur Heart J. 1995;16:1277-1284.
43. Mangoni AA, Mircoli L, Giannattasio C, Mancia G, Ferrari AU. Effect of sympathectomy on mechanical properties of common carotid and femoral arteries. Hypertension. 1997;30:1085-1088.
44. Jern S, Wall U, Bergbrant A. Long-term stability of blood pressure and pressor reactivity to mental stress in borderline hypertension. Am J Hypertens. 1995;8:20-28.
45. Sacks FM, Dzau VJ. Adrenergic effects on plasma lipoprotein metabolism: speculation on mechanisms of action. Am J Med. 1988;80(suppl 2A):71-81.
46. Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, Baron AD. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation. 1997;96:3287-3293.
47. Nickenig G, Jung O, Strehlow K, Zolk O, Linz W, Scholkens BA, Bohm M. Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression. Am J Physiol. 1997;272:H2701-H2707.
48. Hirsch EZ, Maksem JA, Gagen D. Effects of stress and propanolol on aortic intima of rats. Atherosclerosis. 1984;4:526.